Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs6265
rs6265
0.040 GeneticVariation BEFREE Studies suggest that a functional polymorphism of the brain-derived neurotrophic factor gene (BDNF Val66Met) may contribute to methamphetamine dependence. 26280836

2015

dbSNP: rs6265
rs6265
0.040 GeneticVariation BEFREE BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence. 26401760

2015

dbSNP: rs6265
rs6265
0.040 GeneticVariation BEFREE In conclusion, the rs6265 polymorphism may be a risk factor for methamphetamine dependence in south Asian subjects or for heroin dependence in Chinese subjects. 24279859

2013

dbSNP: rs6265
rs6265
0.040 GeneticVariation BEFREE Our findings suggest that the BDNF Val66Met polymorphism may contribute to methamphetamine dependence and psychosis in the Chinese population but not in other Malaysian ethnicities. 20736000

2010

dbSNP: rs759834365
rs759834365
0.030 GeneticVariation BEFREE BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence. 26401760

2015

dbSNP: rs759834365
rs759834365
0.030 GeneticVariation BEFREE Studies suggest that a functional polymorphism of the brain-derived neurotrophic factor gene (BDNF Val66Met) may contribute to methamphetamine dependence. 26280836

2015

dbSNP: rs759834365
rs759834365
0.030 GeneticVariation BEFREE Our findings suggest that the BDNF Val66Met polymorphism may contribute to methamphetamine dependence and psychosis in the Chinese population but not in other Malaysian ethnicities. 20736000

2010

dbSNP: rs324420
rs324420
0.020 GeneticVariation BEFREE Our findings suggest that the FAAH Pro129Thr polymorphism may contribute to methamphetamine dependence in the Malay and Chinese ethnic groups. 23556448

2013

dbSNP: rs324420
rs324420
0.020 GeneticVariation BEFREE To clarify a possible involvement of FAAH in the etiology of methamphetamine dependence/psychosis or schizophrenia, we examined the genetic association of a nonsynonymous polymorphism of the FAAH gene (Pro129Thr) by a case-control study. 15721218

2005

dbSNP: rs3213207
rs3213207
0.010 GeneticVariation BEFREE Our results indicated that the DTNBP1 rs3213207 polymorphism did not show any significant association with risk of methamphetamine dependence, either in the pooled subjects or after stratification into the 4 different ethnic groups (P > 0.05). 25303981

2015

dbSNP: rs1630250
rs1630250
0.010 GeneticVariation BEFREE rs1630250 was associated in males with methamphetamine dependence in the allele analysis (P-value: 0.0253). 21683752

2011

dbSNP: rs6662926
rs6662926
0.010 GeneticVariation BEFREE We conducted a case-control study of Japanese individuals (215 with methamphetamine dependence and 318 age- and sex-matched controls) with three tagging SNPs (rs1630250, rs766288 and rs6662926) selected by HapMap database. 21683752

2011

dbSNP: rs16147
rs16147
0.010 GeneticVariation BEFREE The single nucleotide polymorphisms rs16147 of the NPY gene (-485C>T) and rs7687423 of the NPY receptor Y1 (NPY1R) gene were analyzed in 222 patients with methamphetamine dependence and psychosis and 288 age- and gender-matched controls. 19566775

2009

dbSNP: rs7687423
rs7687423
0.010 GeneticVariation BEFREE The single nucleotide polymorphisms rs16147 of the NPY gene (-485C>T) and rs7687423 of the NPY receptor Y1 (NPY1R) gene were analyzed in 222 patients with methamphetamine dependence and psychosis and 288 age- and gender-matched controls. 19566775

2009

dbSNP: rs135745
rs135745
0.010 GeneticVariation BEFREE There was also no significant association between rs135745 and the clinical characteristics of methamphetamine dependence and co-morbid methamphetamine psychosis (e.g., age of first consumption, latency of psychosis, prognosis of psychosis after therapy, spontaneous relapse of psychotic symptoms, and poly-substance abuse status). 18991847

2008